CNS5:Volunteer Assignments and Opportunities: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
Author content - pending or complete - column
 
(23 intermediate revisions by 2 users not shown)
Line 5: Line 5:
If empty (no name is present), please volunteer to create content for that disease!
If empty (no name is present), please volunteer to create content for that disease!


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
 
__TOC__
<br />
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
Line 19: Line 18:
!'''Notes'''
!'''Notes'''
|-
|-
|Astrocystoma, IDH-Mutant
|
====CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
|Disease
|Disease
|Meenakshi Mehrotra
|Meenakshi Mehrotra
|6/25/2023
|6/25/2023
|
|
|PENDING
|COMPLETE
|
|
|Laveniya Satgunaseelan (LS)
|Laveniya Satgunaseelan (LS)
Line 30: Line 50:
|2021 template added
|2021 template added
|-
|-
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
|Disease
|Riley Lochner (trainee), Shashi Shetty (mentor)
|6/7/2022
|6/7/2022
|
|
Line 39: Line 61:
|2021 template added
|2021 template added
|-
|-
|Glioblastoma, IDH-Wildtype||Disease||Meenakshi Mehrotra
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
|Disease
|
|
|
|
|
|
|
|PENDING
|
|
|LS
|
|
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
|Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
|-
|-
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||Scott Smith
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
|Disease
|Scott Smith
|6/27/2023
|6/27/2023
|
|
|PENDING
|COMPLETE
|
|
|LS
|LS
Line 57: Line 83:
|2021 template added (page created 6/27/23)
|2021 template added (page created 6/27/23)
|-
|-
|Angiocentric Glioma||Disease||
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
|Disease
|
|
|
|
|
Line 66: Line 94:
|
|
|-
|-
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
|Disease
|
|
|
|
|
Line 75: Line 105:
|
|
|-
|-
|Diffuse Low-Grade Glioma, MAPK Pathway-Altered||Disease||
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
|
|Disease
|
|Scott Smith
|
|5/3/2024
|
|
|PENDING - email reminder 9/4/2025
|
|
|LS
|
|
|
|
|-
|-
|Diffuse Midline Glioma, H3 K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
|Disease
|Laveniya Satgunaseelan  
|
|
|
|
Line 93: Line 127:
|2021 template added
|2021 template added
|-
|-
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
|Disease
|Xiaolin (Lynn) Hu
|2/21/2022
|2/21/2022
|
|
Line 102: Line 138:
|2021 template added
|2021 template added
|-
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
|Disease
|Madina Sukhanova
|10/28/2022
|10/28/2022
|
|
Line 111: Line 160:
|2021 template added
|2021 template added
|-
|-
|Infant-Type Hemispheric Glioma||Disease||
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
|Disease
|
|
|
|
|
|
Line 118: Line 170:
|
|
|
|
|2021 template added
|-
|-
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
|9/13/2022<br />
|Disease
|
|<br />
|
|
|
|PENDING
|
|
|LS
|LS
Line 129: Line 182:
|2021 template added
|2021 template added
|-
|-
|High-Grade Astrocytoma with Piloid Features||Disease||
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
|Disease
|
|
|
|
|
Line 138: Line 193:
|
|
|-
|-
|Pleomorphic Xanthoastrocytoma||Disease||
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
|
|Disease
|
|Wahab Khan
|15/04/2025
|
|
|PENDING - email reminder 9/4/2025
|
|
|LS
|LS
Line 147: Line 204:
|2021 template added
|2021 template added
|-
|-
|Subependymal Giant Cell Astrocytoma||Disease||
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
|Disease
|
|
|
|
|
Line 156: Line 215:
|
|
|-
|-
|Chordoid Glioma||Disease||
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
|Disease
|
|
|
|
|
Line 165: Line 226:
|
|
|-
|-
|Astroblastoma, MN1-Altered||Disease||
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
|Disease
|
|
|
|
|
Line 174: Line 237:
|
|
|-
|-
|Ganglioglioma||Disease||Leila Moayed-Aloei
|[[CNS5:Ganglioglioma|Ganglioglioma]]
|Disease
|Leila Moayed-Aloei
|6/30/2022
|6/30/2022
|
|
Line 183: Line 248:
|2021 template added
|2021 template added
|-
|-
|Gangliocytoma||Disease||
|[[CNS5:Gangliocytoma|Gangliocytoma]]
|Disease
|
|
|
|
Line 191: Line 257:
|
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
|Disease
|
|
|
|
|
Line 201: Line 281:
|
|
|-
|-
|Dysembryoplastic Neuroepithelial Tumour||Disease||
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
|Disease
|
|
|
|
|
Line 210: Line 292:
|
|
|-
|-
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
|Disease
|
|
|
|
|
Line 219: Line 303:
|
|
|-
|-
|Papillary Glioneuronal Tumour||Disease||
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
|Disease
|
|
|
|
|
Line 228: Line 314:
|
|
|-
|-
|Rosette-Forming Glioneuronal Tumour||Disease||
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
|Disease
|
|
|
|
|
Line 237: Line 325:
|
|
|-
|-
|Myxoid Glioneuronal Tumour||Disease||
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
|Disease
|
|
|
|
|
Line 246: Line 336:
|
|
|-
|-
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
|
|Disease
|Laveniya Satgunaseelan
|9/11/2024
|
|COMPLETE
|8/7/2025
|LS
|LS
|Used for testing 9/2024 somatic template
|-
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
|Disease
|
|
|
|
|
|
Line 255: Line 358:
|
|
|-
|-
|Multinodular and Vacuolating Neuronal Tumour||Disease||
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
|Disease
|
|
|
|
|
Line 264: Line 369:
|
|
|-
|-
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
|Disease
|
|
|
|
|
Line 273: Line 380:
|
|
|-
|-
|Central Neurocytoma||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
|Disease
|
|
|
|
|
Line 282: Line 402:
|
|
|-
|-
|Extraventricular Neurocytoma||Disease||
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
|Disease
|
|
|
|
|
Line 291: Line 413:
|
|
|-
|-
|Cerebellar Liponeurocytoma||Disease||
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
|Disease
|
|
|
|
|
Line 300: Line 424:
|
|
|-
|-
|Supratentorial Ependymoma||Disease||
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
|Disease
|
|
|
|
|
Line 309: Line 435:
|
|
|-
|-
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
|Disease
|
|
|
|
|
Line 318: Line 446:
|
|
|-
|-
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
|Disease
|
|
|
|
|
Line 327: Line 457:
|
|
|-
|-
|Posterior Fossa Ependymoma||Disease||
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
|Disease
|
|
|
|
|
Line 336: Line 468:
|
|
|-
|-
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
|Disease
|
|
|
|
|
Line 345: Line 479:
|
|
|-
|-
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
|Disease
|
|
|
|
|
Line 354: Line 490:
|
|
|-
|-
|Spinal Ependymoma||Disease||
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
|Disease
|
|
|
|
Line 362: Line 499:
|
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|Spinal Ependymoma, MYCN-Amplified||Disease||
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
|Disease
|
|
|
|
|
Line 372: Line 523:
|
|
|-
|-
|Myxopapillary Ependymoma||Disease||
|[[CNS5:Subependymoma|Subependymoma]]
|Disease
|
|
|
|
|
Line 381: Line 534:
|
|
|-
|-
|Subependymoma||Disease||
|
|
====CHAPTER 3 (CHOROID PLEXUS TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Choroid Plexus Papilloma||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
|Disease
|
|
|
|
|
|
|
|
|-
|Atypical Choroid Plexus Papilloma||Disease||
|
|
|
|
|
|
|
|
|-
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
|Disease
|
|
|
|
|-
|Choroid Plexus Carcinoma||Disease||
|
|
|
|
Line 417: Line 577:
|
|
|-
|-
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
|9/20/21
|Disease
|
|
|COMPLETE
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
|
|
|
|
Line 435: Line 588:
|
|
|-
|-
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
|
|
|
====CHAPTER 4 (EMBRYONAL TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
|
|
|
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|Medulloblastoma, Histologically Defined||Disease||
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
|Disease
|Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|
|COMPLETE
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
|Disease
|
|
|
|
|
Line 462: Line 631:
|
|
|-
|-
|Atypical Teratoid/Rhabdoid Tumour||Disease||
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
|Disease
|
|
|
|
|
Line 471: Line 642:
|
|
|-
|-
|Cribriform Neuroepithelial Tumour||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
|Disease
|
|
|
|
|
Line 480: Line 664:
|
|
|-
|-
|Embryonal Tumour with Multilayered Rosettes||Disease||
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
|Disease
|
|
|
|
|
Line 489: Line 675:
|
|
|-
|-
|CNS Neuroblastoma, FOXR2-Activated||Disease||
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
|Disease
|
|
|
|
|
Line 498: Line 686:
|
|
|-
|-
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
|Disease
|
|
|
|
|
Line 507: Line 697:
|
|
|-
|-
|CNS Embryonal Tumour NEC/NOS||Disease||
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
|Disease
|
|
|
|
|
Line 516: Line 708:
|
|
|-
|-
|Pineocytoma||Disease||
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
|Disease
|
|
|
|
|
Line 525: Line 719:
|
|
|-
|-
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
|Disease
|
|
|
|
|
Line 534: Line 730:
|
|
|-
|-
|Pineoblastoma||Disease||
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
|Disease
|
|
|
|
|
Line 543: Line 741:
|
|
|-
|-
|Papillary Tumour of the Pineal Region||Disease||
|
|
====CHAPTER 5 (PINEAL TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
|
|
|
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Pineocytoma|Pineocytoma]]
|Disease
|
|
|-
|Schwannoma||Disease||
|
|
|
|
Line 570: Line 773:
|
|
|-
|-
|Neurofibroma||Disease||
!'''Disease'''
|
!'''Page Type'''
|
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
|Disease
|
|
|
|
|
|
|
Line 579: Line 795:
|
|
|-
|-
|Perineurioma||Disease||
|[[CNS5:Pineoblastoma|Pineoblastoma]]
|Disease
|
|
|
|
|
Line 588: Line 806:
|
|
|-
|-
|Hybrid Nerve Sheath Tumours||Disease||
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
|Disease
|
|
|
|
|
Line 597: Line 817:
|
|
|-
|-
|Malignant Melanotic Nerve Sheath Tumour||Disease||
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
|Disease
|
|
|
|
|
Line 606: Line 828:
|
|
|-
|-
|Malignant Peripheral Nerve Sheath Tumour||Disease||
|
|
====CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Schwannoma|Schwannoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|Meningioma||Disease||
|
|
|
|
|
|
|
|
|-
|[[CNS5:Neurofibroma|Neurofibroma]]
|Disease
|
|
|
|
|
|-
|Solitary Fibrous Tumour||Disease||
|
|
|
|
Line 640: Line 870:
|
|
|
|
|-
|[[CNS5:Perineurioma|Perineurioma]]
|Disease
|
|
|-
|Haemangiomas and Vascular Malformations||Disease||
|
|
|
|
Line 651: Line 882:
|
|
|-
|-
|Haemangioblastoma||Disease||
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
|Disease
|
|
|
|
|
Line 660: Line 893:
|
|
|-
|-
|Rhabdomyosarcoma||Disease||
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|
|
|
|
|
Line 669: Line 904:
|
|
|-
|-
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|
|
|
|
|
Line 678: Line 926:
|
|
|-
|-
|CIC-Rearranged Sarcoma||Disease||
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
|Disease
|
|
|
|
|
Line 687: Line 937:
|
|
|-
|-
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
|
|
====CHAPTER 7 (MENINGIOMA)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Ewing Sarcoma||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Meningioma|Meningioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|Mesenchymal Chondrosarcoma||Disease||
|
|
|
|
|
|
|
|
|-
|
|
====CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)====
|
|
----
|
|
|-
----
|Chondrosarcoma||Disease||
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|Chordoma||Disease||
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|
|
|
|
|
Line 732: Line 1,001:
|
|
|-
|-
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
|Disease
|
|
|
|
|
Line 741: Line 1,012:
|
|
|-
|-
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
|Disease
|
|
|
|
|
Line 750: Line 1,023:
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
|Disease
|
|
|
|
|
Line 759: Line 1,034:
|
|
|-
|-
|Immunodeficiency-Associated CNS Lymphomas||Disease||
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
|Disease
|
|
|
|
|
Line 768: Line 1,045:
|
|
|-
|-
|Lymphomatoid Granulomatosis||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|
|
|
|
|
Line 777: Line 1,067:
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease||
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
|Disease
|
|
|
|
|
Line 786: Line 1,078:
|
|
|-
|-
|MALT Lymphoma of the Dura||Disease||
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|
|
|
|
|
Line 795: Line 1,089:
|
|
|-
|-
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|
|
|
|
|
Line 804: Line 1,100:
|
|
|-
|-
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||Jennie Thurston
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
|7/2/2023
|Disease
|
|
|
|PENDING
|
|
|MS
|
|
|2021 template added
|-
|T-cell and NK/T-cell Lymphomas||Disease||
|
|
|
|
|
|
|
|-
|[[CNS5:Chordoma|Chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
|
|
|
|
|
|-
|
|
====CHAPTER 9 (MELANOCYTIC TUMOURS)====
|
|
----
|
|
|-
----
|Rosai-Dorfman Disease||Disease||
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|Juvenile Xanthogranuloma||Disease||
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
|Disease
|
|
|
|
|
Line 849: Line 1,154:
|
|
|-
|-
|Langerhans Cell Histiocytosis||Disease||
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
|Disease
|
|
|
|
|
Line 858: Line 1,165:
|
|
|-
|-
|Histiocytic Sarcoma||Disease||
|
|
====CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Germ Cell Tumours of the CNS||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
|Disease
|
|
|
|
|
|
|
|
|-
|Adamantinomatous Craniopharyngioma||Disease||
|
|
|
|
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
|Disease
|
|
|
|
|
|
|-
|Papillary Craniopharyngioma||Disease||
|
|
|
|
Line 891: Line 1,218:
|
|
|
|
|-
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
|Disease
|
|
|
|
|-
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
|
|
|
|
Line 901: Line 1,229:
|
|
|
|
|-
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
|Disease
|
|
|-
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
|
|
|
|
Line 912: Line 1,241:
|
|
|-
|-
|Pituitary Blastoma||Disease||
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
|Disease
|
|
|
|
|
Line 921: Line 1,252:
|
|
|-
|-
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
|Disease
|
|
|
|
|
Line 930: Line 1,263:
|
|
|-
|-
|Metastases to the Meninges||Disease||
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
|Disease
|Jennie Thurston
|7/2/2023
|
|
|PENDING
|
|
|MS
|
|
|2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "[[HAEM5:ALK-positive anaplastic large cell lymphoma|ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]" and "[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]"?
|-
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
|
|
|
|
|
|
|
|
|-
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
|Disease
|
|
|
|
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Neurofibromatosis Type 2||Disease||
|
|
|
|
Line 955: Line 1,295:
|
|
|
|
|-
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|
|
|-
|Schwannomatosis||Disease||
|
|
|
|
Line 966: Line 1,307:
|
|
|-
|-
|Von Hippel-Lindau Syndrome||Disease||
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
|Disease
|
|
|
|
|
Line 975: Line 1,318:
|
|
|-
|-
|Tuberous Sclerosis||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|Disease
|
|
|
|
|
Line 984: Line 1,340:
|
|
|-
|-
|Li-Fraumeni Syndrome||Disease||
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|Disease
|
|
|
|
|
Line 993: Line 1,351:
|
|
|-
|-
|Cowden Syndrome||Disease||
|
|
====CHAPTER 11 (GERM CELL TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||Jennie Thurston
|7/2/2023
|
|
|PENDING
----
|
|
|LS
----
|
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
----
|-
|-
|Familial Adenomatous Polyposis 1||Disease||Jennifer Laffin
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
|8/22/2023
|Disease
|
|
|
|PENDING
|
|
|LS/MS
|
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
|
|
|
|
|
|
|
|
|-
|
|
====CHAPTER 12 (TUMOURS OF THE SELLAR REGION====
|
|
----
|
|
|-
----
|Rhabdoid Tumour Predisposition Syndrome||Disease||
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|Carney Complex||Disease||
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
|Disease
|
|
|
|
|
Line 1,047: Line 1,415:
|
|
|-
|-
|DICER1 Syndrome||Disease||Jennie Thurston
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
|7/2/2023
|Disease
|
|
|PENDING
|
|
|LS
|
|
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Familial Paraganglioma Syndromes||Disease||
|
|
|
|
Line 1,062: Line 1,425:
|
|
|
|
|-
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
|Disease
|
|
|
|
|-
|Melanoma-Astrocytoma Syndrome||Disease||
|
|
|
|
Line 1,072: Line 1,436:
|
|
|
|
|-
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
|Disease
|
|
|-
|Familial Retinoblastoma||Disease||
|
|
|
|
Line 1,083: Line 1,448:
|
|
|-
|-
|BAP1 Tumour Predisposition Syndrome||Disease||
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
|
|Disease
|
|
|
|
|
|
Line 1,092: Line 1,459:
|
|
|-
|-
|Fanconi Anaemia||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
====CHAPTER 13 (METASTASES TO THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|-
|-
|ELP1-Medulloblastoma Syndrome||Disease||
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
|Disease
|
|
|
|
|
Line 1,110: Line 1,502:
|
|
|-
|-
|}<br />
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
{| class="wikitable" style="margin:auto"
|Disease
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
|
|
|
|
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
|Disease
|Meenakshi Mehrotra
|6/25/2023
|
|
|PENDING
====CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)====
|
|
|Laveniya Satgunaseelan (LS)
----
|
|
|2021 template added
----
|-
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
|Disease
|Riley Lochner (trainee), Shashi Shetty (mentor)
|6/7/2022
|
|
|COMPLETE
----
|
|
|LS
----
|
|
|2021 template added
----
|-
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
|Disease
|Meenakshi Mehrotra
|
|
----
|
|
|PENDING
----
|
|
|LS
----
|
|
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
----
|-
|-
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
|Disease
|Disease
|Scott Smith
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|6/27/2023
|N/A
|
|N/A
|PENDING
|N/A
|
|N/A
|LS
|N/A
|
|N/A
|2021 template added (page created 6/27/23)
|N/A
|-
|-
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
|[[CNS5:Schwannomatosis|Schwannomatosis]]
|Disease
|Disease
|
|
Line 1,177: Line 1,567:
|
|
|-
|-
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
|Disease
|Disease
|
|
Line 1,199: Line 1,589:
|
|
|-
|-
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|Disease
|Laveniya Satgunaseelan (Linda Cooley - previous version)
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
|Disease
|[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
|Disease
|
|
|
|
|
|
|
|
|PENDING
|
|
|LS
|
|
|2021 template added
|-
|-
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
|Disease
|Disease
|Xiaolin (Lynn) Hu
|2/21/2022
|
|
|COMPLETE
|
|
|LS
|
|
|2021 template added
|-
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
|Disease
|Madina Sukhanova
|10/28/2022
|
|
|COMPLETE
|
|
|LS
|
|
|2021 template added
|
|
|-
|-
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
|[[CNS5:Carney_complex|Carney complex]]
|Disease
|Disease
|
|
Line 1,241: Line 1,675:
|
|
|
|
|2021 template added
|
|-
|-
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
|Disease
|Disease
|Jeremy Pulvers
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|9/13/2022<br />
|N/A
|
|N/A
|PENDING
|N/A
|
|N/A
|LS
|N/A
|
|N/A
|2021 template added
|N/A
|-
|-
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
|Disease
|Disease
|
|
Line 1,265: Line 1,699:
|
|
|-
|-
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
|Disease
|
|
|
|
|
|LS
|
|2021 template added
|-
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
|Disease
|Disease
|
|
Line 1,287: Line 1,710:
|
|
|-
|-
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
|Disease
|Disease
|
|
Line 1,298: Line 1,721:
|
|
|-
|-
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
!'''Disease'''
|Disease
!'''Page Type'''
|
!'''<span style="color:#0070C0">Author'''
|
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
|
!'''Date Completed by Author'''
|
!'''Associate Editor'''
|
!'''Date of Last Editor Review'''
|
!'''Notes'''
|-
|[[CNS5:Ganglioglioma|Ganglioglioma]]
|Disease
|Leila Moayed-Aloei
|6/30/2022
|
|COMPLETE
|
|LS
|
|2021 template added
|-
|[[CNS5:Gangliocytoma|Gangliocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Subependymoma|Subependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
|Disease
|Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|
|COMPLETE
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pineocytoma|Pineocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pineoblastoma|Pineoblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Schwannoma|Schwannoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Neurofibroma|Neurofibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Perineurioma|Perineurioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Meningioma|Meningioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Chordoma|Chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
|Disease
|Jennie Thurston
|7/2/2023
|
|PENDING
|
|MS
|
|2021 template added
|-
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|Ngoni Faya (trainee) + Madina Sukhanova
|
|
|
|
|
|
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Schwannomatosis|Schwannomatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
|Disease
|Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
|Disease
|Jennifer Laffin
|8/22/2023
|
|PENDING
|
|LS/MS
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Carney_complex|Carney complex]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
|Disease
|Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
Line 2,433: Line 1,745:
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]

Latest revision as of 05:03, 4 September 2025

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Tumours of the Central Nervous System (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)
Astrocytoma, IDH-mutant Disease Meenakshi Mehrotra 6/25/2023 COMPLETE Laveniya Satgunaseelan (LS) 2021 template added
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Disease Riley Lochner (trainee), Shashi Shetty (mentor) 6/7/2022 COMPLETE LS 2021 template added
Glioblastoma, IDH-wildtype Disease Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
Diffuse astrocytoma, MYB- or MYBL1-altered Disease Scott Smith 6/27/2023 COMPLETE LS 2021 template added (page created 6/27/23)
Angiocentric glioma Disease
Polymorphous low-grade neuroepithelial tumour of the young Disease
Diffuse low-grade glioma, MAPK pathway-altered Disease Scott Smith 5/3/2024 PENDING - email reminder 9/4/2025 LS
Diffuse midline glioma, H3 K27-altered Disease Laveniya Satgunaseelan PENDING LS 2021 template added
Diffuse hemispheric glioma, H3 G34-mutant Disease Xiaolin (Lynn) Hu 2/21/2022 COMPLETE LS 2021 template added
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype Disease Madina Sukhanova 10/28/2022 COMPLETE LS 2021 template added
Infant-type hemispheric glioma Disease
Pilocytic astrocytoma Disease
LS 2021 template added
High-grade astrocytoma with piloid features Disease
Pleomorphic xanthoastrocytoma Disease Wahab Khan 15/04/2025 PENDING - email reminder 9/4/2025 LS 2021 template added
Subependymal giant cell astrocytoma Disease
Chordoid glioma Disease
Astroblastoma, MN1-altered Disease
Ganglioglioma Disease Leila Moayed-Aloei 6/30/2022 COMPLETE LS 2021 template added
Gangliocytoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma Disease
Dysembryoplastic neuroepithelial tumour Disease
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters Disease
Papillary glioneuronal tumour Disease
Rosette-forming glioneuronal tumour Disease
Myxoid glioneuronal tumour Disease
Diffuse leptomeningeal glioneuronal tumour Disease Laveniya Satgunaseelan 9/11/2024 COMPLETE 8/7/2025 LS LS Used for testing 9/2024 somatic template
Multinodular and vacuolating neuronal tumour Disease
Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) Disease
Central neurocytoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Extraventricular neurocytoma Disease
Cerebellar liponeurocytoma Disease
Supratentorial ependymoma Disease
Supratentorial ependymoma, ZFTA fusion-positive Disease
Supratentorial ependymoma, YAP1 fusion-positive Disease
Posterior fossa ependymoma Disease
Posterior fossa group A (PFA) ependymoma Disease
Posterior fossa group B (PFB) ependymoma Disease
Spinal ependymoma Disease
Spinal ependymoma, MYCN-amplified Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Myxopapillary ependymoma Disease
Subependymoma Disease

CHAPTER 3 (CHOROID PLEXUS TUMOURS)
Choroid plexus papilloma Disease
Atypical choroid plexus papilloma Disease
Choroid plexus carcinoma Disease

CHAPTER 4 (EMBRYONAL TUMOURS)
Medulloblastoma, WNT-activated Disease Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City 9/20/21 COMPLETE Holli Drendel (interim)/Laveniya Satgunaseelan (LS) 9/22/2022 2021 template added
Medulloblastoma, SHH-activated and TP53-wildtype Disease
Medulloblastoma, SHH-activated and TP53-mutant Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Medulloblastoma, non-WNT/non-SHH Disease
Medulloblastoma, histologically defined Disease
Atypical teratoid/rhabdoid tumour Disease
Cribriform neuroepithelial tumour Disease
Embryonal tumour with multilayered rosettes Disease
CNS neuroblastoma, FOXR2-activated Disease
CNS tumour with BCOR internal tandem duplication Disease
CNS embryonal tumour NEC/NOS Disease

CHAPTER 5 (PINEAL TUMOURS)
Pineocytoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Pineal parenchymal tumour of intermediate differentiation Disease
Pineoblastoma Disease
Papillary tumour of the pineal region Disease
Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant Disease

CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Hybrid nerve sheath tumours Disease
Malignant melanotic nerve sheath tumour Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Malignant peripheral nerve sheath tumour Disease
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease

CHAPTER 7 (MENINGIOMA)
Meningioma Disease

CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)
Solitary fibrous tumour Disease
Haemangiomas and vascular malformations Disease
Haemangioblastoma Disease
Rhabdomyosarcoma Disease
Intracranial mesenchymal tumour, FET::CREB fusion-positive Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CIC-rearranged sarcoma Disease
Primary intracranial sarcoma, DICER1-mutant Disease
Ewing sarcoma Disease
Mesenchymal chondrosarcoma Disease
Chondrosarcoma Disease
Chordoma Disease

CHAPTER 9 (MELANOCYTIC TUMOURS)
Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis Disease
Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma Disease

CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)
Primary diffuse large B-cell lymphoma of the CNS Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Immunodeficiency-associated CNS lymphomas Disease
Lymphomatoid granulomatosis Disease
Intravascular large B-cell lymphoma Disease
MALT lymphoma of the dura Disease
Other low-grade B-cell lymphomas of the CNS Disease
Anaplastic large cell lymphoma (ALK+/ALK−) Disease Jennie Thurston 7/2/2023 PENDING MS 2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)" and "ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)"?
T-cell and NK/T-cell lymphomas Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
Juvenile xanthogranuloma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Langerhans cell histiocytosis Disease
Histiocytic sarcoma Disease

CHAPTER 11 (GERM CELL TUMOURS)
Germ cell tumours of the CNS Disease

CHAPTER 12 (TUMOURS OF THE SELLAR REGION
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma Disease
Pituitary adenoma / pituitary neuroendocrine tumour Disease
Pituitary blastoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 13 (METASTASES TO THE CNS)
Metastases to the brain and spinal cord parenchyma Disease
Metastases to the meninges Disease

CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Neurofibromatosis type 2 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Schwannomatosis Disease
Von Hippel-Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Tuberous sclerosis Disease
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Cowden syndrome Disease See DIG5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Constitutional mismatch repair deficiency syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Familial adenomatous polyposis 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Naevoid basal cell carcinoma syndrome Disease
Rhabdoid tumour predisposition syndrome Disease
Carney complex Disease
DICER1 syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Familial paraganglioma syndromes Disease
Melanoma-astrocytoma syndrome Disease
Familial retinoblastoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
BAP1 tumour predisposition syndrome Disease
Fanconi anaemia Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
ELP1-medulloblastoma syndrome Disease
Retrieved from "https://test.ccga.io/index.php?title=CNS5:Volunteer_Assignments_and_Opportunities&oldid=19266"